Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
Clinical trial NCT00644020 · UNKNOWN
Trial details
- NCT number
- NCT00644020
- Sponsor
- Shenzhen Kangzhe Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2007-12-01
- Primary completion
- 2008-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.